Treating Myeloproliferation--On Target or Off?
From the Departments of Oncology (M.A.) and Molecular Biology and Genetics (C.W.G.) and the Sidney Kimmel Comprehensive Cancer Center (M.A., C.W.G.), Johns Hopkins University School of Medicine, Baltimore.
Mary
M
Armanios
Carol W
CW
Greider
D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives*; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D019098:Telomerase / Q000037:antagonists & inhibitors*; D013920:Thrombocythemia, Essential / Q000188:drug therapy*
D007211:Indoles; D009536:Niacinamide; D019098:Telomerase